Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Abliva Cash from Financing (TTM): 0.0391M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.0391M |
September 30, 2023 | 0.9292M |
June 30, 2023 | 3.930M |
March 31, 2023 | 17.83M |
December 31, 2022 | 20.38M |
September 30, 2022 | 19.58M |
June 30, 2022 | 16.35M |
March 31, 2022 | 11.47M |
December 31, 2021 | 8.855M |
September 30, 2021 | 8.510M |
June 30, 2021 | 11.34M |
March 31, 2021 | 7.895M |
December 31, 2020 | 7.897M |
September 30, 2020 | 8.299M |
June 30, 2020 | 5.544M |
March 31, 2020 | -0.42M |
December 31, 2019 | 11.38M |
September 30, 2019 | 11.52M |
June 30, 2019 | 11.45M |
March 31, 2019 | 19.24M |
December 31, 2018 | 7.450M |
September 30, 2018 | 7.702M |
June 30, 2018 | 8.470M |
March 31, 2018 | 1.073M |
December 31, 2017 | 1.073M |
Date | Value |
---|---|
September 30, 2017 | 0.5168M |
June 30, 2017 | -0.353M |
March 31, 2017 | 9.049M |
December 31, 2016 | 9.049M |
September 30, 2016 | 9.177M |
June 30, 2016 | 9.383M |
March 31, 2016 | 6.825M |
December 31, 2015 | 16.42M |
September 30, 2015 | 16.50M |
June 30, 2015 | 16.06M |
March 31, 2015 | 8.949M |
December 31, 2014 | 11.21M |
September 30, 2014 | 16.19M |
June 30, 2014 | 16.77M |
March 31, 2014 | 17.02M |
December 31, 2013 | 5.161M |
September 30, 2013 | -0.0252M |
June 30, 2013 | 0.1679M |
March 31, 2013 | 6.845M |
December 31, 2012 | 6.845M |
September 30, 2012 | 6.870M |
June 30, 2012 | 6.740M |
March 31, 2012 | 0.0632M |
December 31, 2011 | 0.0632M |
September 30, 2011 | 0.095M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.42M
Minimum
Mar 2020
20.38M
Maximum
Dec 2022
9.619M
Average
8.855M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
Karolinska Development AB | -0.0782M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | 11.82M |
Olink Holding AB | 92.50M |
BioInvent International AB | -0.8002M |